E. Pongo et al., Deterioration of the protein kinase C-K-ATP channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits, EUR J PHARM, 418(3), 2001, pp. 217-223
We studied the effect of experimental hypercholesterolaemia/atherosclerosis
on changes in coronary flow and cardiac function, induced by protein kinas
e C and ATP-sensitive K+ (K-ATP) channel modulators in isolated Langendorff
-perfused rabbit hearts. Both phorbol 12-myristate-13-acetate (PMA) and pho
rbol 12,13-dibutyrate (PDB, 0.1 muM each), activators of protein kinase C,
decreased, whereas staurosporine. (0.1)muM), a protein kinase C inhibitor,
increased coronary flow and left ventricular dP/dt, an index of ventricular
contractility. Glyburide (5-50 muM), a K-ATP channel inhibitor, blocked th
e effect of staurosporine. The phorbol esters were without effect in the pr
esence of pinacidil (5 muM), a K-ATP channel activator. Neither the protein
kinase C modulators nor glyburide produced any effect on coronary flow and
left ventricular contractility, when the hearts were prepared from animals
either maintained on a cholesterol (1.5%)-enriched diet or treated with lo
vastatin (5 mg/kg/day per os). Treatment with farnesol (1 mg/kg twice a day
for 7 days intravenously) restored the reactivity of hearts from either hy
percholesterolaemic or lovastatin-treated animals to protein kinase C modul
ators. We conclude that non-cholesterol mevalonate products are necessary f
or the functional integrity of the protein kinase C-K-ATP channel pathway i
n the rabbit heart. (C) 2001 Published by Elsevier Science B.V.